CLINICAL_TRIALS
withdrawal
· 2015-12-17
Clinical Trial Update: Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN) [Phase 2]
Summary
A Phase 2 trial evaluating SCH 900435 for schizophrenia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Schizophrenia | Phase 2 | Status: WITHDRAWN